Immune system cells called T cells (orange) have detected a cancer cell and attached to it. Innovative drugs pioneered by Memorial Sloan Kettering researchers stimulate the ability of T cells to recognize and destroy cancer cells.
For more than a century, researchers have looked for ways to take advantage of a tantalizing concept — that a person’s immune system is inherently capable of responding to cancer and can be harnessed to effectively defend against it. Recent breakthroughs made here have brought this idea into clinical practice, and we continue advancing immune-based therapies to transform cancer care.
